Company / Operating Cash Flow per Share
ANI Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$8.78
FY2025
5-year range
-$1.92 / $8.78
FY2021-FY2025
Trend
+122.9%
vs FY2024
Sector context
#13 of 212
Health Care
What the data says
Among 212 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 6% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.92 in FY2022 to $8.78 in FY2025.
Based on SEC 10-K filings.
8.78 in FY2025 with a 5-year CAGR of +47.1%. Top quartile in the Health Care sector.
Improved from $6.54 to $8.78 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +47.1%
- 10-Year CAGR
- -
Sector benchmark
+159.6% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 122.9% year-over-year.
- Ranks #13 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.78 | +122.9% |
| FY2024 | $3.94 | -39.8% |
| FY2023 | $6.54 | +440.7% |
| FY2022 | -$1.92 | -827.6% |
| FY2021 | $0.26 | -79.3% |
| FY2020 | $1.28 | -67.7% |
| FY2019 | $3.95 | -30.6% |
| FY2018 | $5.70 | +67.0% |
| FY2017 | $3.41 | +43.7% |
| FY2016 | $2.37 | +100.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026